deltatrials

Bronchiectasis Trials in Cambridge, United Kingdom

Conditions / Bronchiectasis / Cambridge, United Kingdom

Clinical trials for Bronchiectasis investigate a range of treatment strategies and patient populations.

14 total trials for this combination

Showing top 10 of 14 trials

Trials

NCT ID Title Status Phase
NCT00775138 Safety and Tolerability Study of 2 Dose Level of Arikayce™ in Patients With Bronchiectasis and Chronic Infection Due to Pseudomonas Aeruginosa. COMPLETED PHASE2
NCT06280391 A Proof-of-Concept Study to Assess the Efficacy, Safety and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Non-cystic Fibrosis Bronchiectasis COMPLETED PHASE2
NCT00769119 A Phase II , Placebo-controlled Study to Assess Efficacy of 28 Day Oral AZD9668 in Patients With Bronchiectasis COMPLETED PHASE2
NCT05238675 A Study to Test Whether Different Doses of BI 1291583 Help People With Bronchiectasis COMPLETED PHASE2
NCT06166056 A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Inhaled CHF6333 After Single Doses in Healthy Volunteers and After Single and Repeated Doses in Subjects With Bronchiectasis RECRUITING PHASE1/PHASE2
NCT01764841 Ciprofloxacin Dry Powder for Inhalation in Non-cystic Fibrosis Bronchiectasis (Non-CF BE) COMPLETED PHASE3
NCT01255592 Evaluation of the Effect of AZD5069 in Patients With Bronchiectasis COMPLETED PHASE2
NCT06872892 The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis RECRUITING
NCT00930982 Evaluation of Cipro Inhale in Patients With Non-cystic Fibrosis Bronchiectasis COMPLETED PHASE2
NCT04396366 Study of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of QBW251 in Subjects With Bronchiectasis TERMINATED PHASE2

Related Pages